REFERENCES
- Olynyk J K, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718–724, [INFOTRIEVE], [CSA]
- McDonnell S M, et al. Strategies to increase detection of hemochromatosis. Ann Intern Med. 1998; 129: 987–992, [INFOTRIEVE], [CSA]
- Qaseem A, et al. Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005; 143: 517–521, [INFOTRIEVE], [CSA]
- Yapp T R, Eijkelkamp E J, Powell L W. Population screening for HFE-associated haemochromatosis: Should we have to pay for our genes?. Intern Med J. 2001; 31: 48–52, [INFOTRIEVE], [CSA], [CROSSREF]
- Powell L W. Diagnosis of hemochromatosis. Semin Gastrointest Dis 2002; 13: 80–88, [INFOTRIEVE], [CSA]
- Feder J N, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13: 399–408, [INFOTRIEVE], [CSA], [CROSSREF]
- Beutler E, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996; 22: 187–194, discussion 194a–194b[INFOTRIEVE], [CSA], [CROSSREF]
- Jouanolle A M, et al. Haemochromatosis and HLA-H. Nat Genet. 1996; 14: 251–252, [INFOTRIEVE], [CSA], [CROSSREF]
- Jazwinska E C, et al. Haemochromatosis and HLA-H. Nat Genet. 1996; 14: 249–251, [INFOTRIEVE], [CSA], [CROSSREF]
- Willis G, et al. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis. 1997; 23: 288–291, [INFOTRIEVE], [CSA], [CROSSREF]
- Barton J C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997; 23: 135–145, discussion 145a–145b[INFOTRIEVE], [CSA], [CROSSREF]
- Byrnes V, et al. Genetic hemochromatosis, a Celtic disease: is it now time for population screening?. Genet Test. 2001; 5: 127–130, [INFOTRIEVE], [CSA], [CROSSREF]
- Merryweather-Clarke A T, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997; 34: 275–278, [INFOTRIEVE], [CSA]
- Restagno G., et al. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. Genet Test. 2000; 4: 177–181, [INFOTRIEVE], [CSA], [CROSSREF]
- Carella M, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828–832, [INFOTRIEVE], [CSA]
- Aguilar-Martinez P, et al. Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol. 2001; 114: 914–916, [INFOTRIEVE], [CSA], [CROSSREF]
- Merryweather-Clarke A T, et al. Geography of HFE C282Y and H63D mutations. Genet Test. 2000; 4: 183–198, [INFOTRIEVE], [CSA], [CROSSREF]
- Steinberg K K, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001; 285: 2216–2222, [INFOTRIEVE], [CSA], [CROSSREF]
- Adams P C, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005; 352: 1769–1778, [INFOTRIEVE], [CSA], [CROSSREF]
- Higuchi R, et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 1993; 11: 1026–1030, [CSA], [CROSSREF]
- Birch D E. Simplified hot start PCR. Nature 1996; 381(6581)445–446, [INFOTRIEVE], [CSA], [CROSSREF]
- Watson R M, et al. Increased sample capacity for genotyping and expression profiling by kinetic polymerase chain reaction. Anal Biochem. 2004; 329: 58–67, [INFOTRIEVE], [CSA], [CROSSREF]
- NNSGRC. 2001, National Newborn Screening Report—1998. Austin, TX: National Newborn Screening and Genetics Resource Center
- Lucotte G, Champenois T, Semonin O. A rare case of a patient heterozygous for the hemochromatosis mutation C282Y and homozygous for H63D. Blood Cells Mol Dis 2001; 27: 892–893, [INFOTRIEVE], [CSA], [CROSSREF]
- Thorstensen K, et al. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis. Genet Test. 2000; 4: 371–376, [INFOTRIEVE], [CSA], [CROSSREF]
- Beutler E, West C. Polymorphisms in the 5′ flanking region of the HFE gene: linkage disequilibrium and relationship to iron homeostasis. Blood Cells Mol Dis 2002; 28: 191–195, [INFOTRIEVE], [CSA], [CROSSREF]
- Cardoso C S, et al. Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?. Immunogenetics 2002; 53: 1002–1008, [INFOTRIEVE], [CSA], [CROSSREF]
- Marshall D S, Linfert D R, Tsongalis G J. Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population. Int J Mol Med. 1999; 4: 389–393, [INFOTRIEVE], [CSA]
- Burke W, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998; 280: 172–178, [INFOTRIEVE], [CSA], [CROSSREF]
- Beutler E, et al. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000; 133: 329–337, [INFOTRIEVE], [CSA]
- Barry E, Derhammer T, Elsea S H. Prevalence of three hereditary hemochromatosis mutant alleles in the Michigan Caucasian population. Community Genet 2005; 8: 173–179, [INFOTRIEVE], [CSA], [CROSSREF]
- Barton J C, Acton R T. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama. Genet Test 2000; 4: 199–206, [INFOTRIEVE], [CSA], [CROSSREF]
- Barton J, et al. Iron overload in African Americans. Am J Med. 1995; 99: 616–623, [INFOTRIEVE], [CSA], [CROSSREF]
- Gangaidzo I T, et al. Iron overload in urban Africans in the 1990s. Gut. 1999; 45: 278–283, [INFOTRIEVE], [CSA]
- Acton R T, et al. HFE mutations in African-American women with non-insulin-dependent diabetes mellitus. Ethn Dis. 2001; 11: 578–584, [INFOTRIEVE], [CSA]
- Wurapa R K, et al. Primary iron overload in African Americans. Am J Med. 1996; 101: 9–18, [INFOTRIEVE], [CSA], [CROSSREF]
- Lorey F, et al. Universal newborn screening for Hb H disease in California. Genet Test. 2001; 5: 93–100, [INFOTRIEVE], [CSA], [CROSSREF]
- Pointon J J, et al. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Blood Cells Mol Dis. 2003; 30: 302–306, [INFOTRIEVE], [CSA], [CROSSREF]
- Delatycki M B, et al. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet. 2005; 366: 314–316, [INFOTRIEVE], [CSA], [CROSSREF]
- Schmitt B, Golub R M, Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med 2005; 143: 522–536, [INFOTRIEVE], [CSA]
- Adams P, Brissot P, Powell L W. EASL International Consensus Conference on Haemochromatosis. 2000; 33: 485–504, J Hepatol
- Cadet E, et al. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?. J Med Genet. 2005; 42: 390–395, [INFOTRIEVE], [CSA], [CROSSREF]
- Cogswell M E, et al. HFE genotype and transferrin saturation in the United States. Genet Med. 2003; 5: 304–310, [INFOTRIEVE], [CSA]
- McCune C A, et al. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut. 2006; 55: 554–562, [INFOTRIEVE], [CSA], [CROSSREF]
- Merryweather-Clarke A T, et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol. 1998; 101: 369–373, [INFOTRIEVE], [CSA], [CROSSREF]
- Waalen J, Nordestgaard B G, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005; 18: 203–220, [INFOTRIEVE], [CSA], [CROSSREF]
- Worwood M. Inherited iron loading: genetic testing in diagnosis and management. Blood Rev. 2005; 19: 69–88, [INFOTRIEVE], [CSA], [CROSSREF]
- Lyon E, Frank E L. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem 2001; 47: 1147–1156, [INFOTRIEVE], [CSA]
- Beutler E, et al. Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002; 359: 211–218, [INFOTRIEVE], [CSA], [CROSSREF]
- Willis G, et al. Incidence of liver disease in people with HFE mutations. Gut. 2000; 46: 401–404, [INFOTRIEVE], [CSA], [CROSSREF]
- McCune C A, et al. Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet. 2002; 111: 538–543, [INFOTRIEVE], [CSA], [CROSSREF]
- Andersen R V, et al. Hemochromatosis mutations in the general population: iron overload progression rate. Blood. 2004; 103: 2914–2919, [INFOTRIEVE], [CSA], [CROSSREF]
- Wang X S, et al. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci. 2004; 227: 27–33, [INFOTRIEVE], [CSA]
- Dekker M C, et al. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett. 2003; 348: 117–119, [INFOTRIEVE], [CSA]
- Golub M S, et al. Movement disorders in the Hfe knockout mouse. Nutr Neurosci. 2005; 8: 239–244, [INFOTRIEVE], [CSA], [CROSSREF]
- Berg D, et al. Disturbance of iron metabolism in Parkinson's disease—ultrasonography as a biomarker. Neurotox Res. 2006; 9: 1–13, [INFOTRIEVE], [CSA]
- Lee S Y, Connor J R. Regulation of Hfe by stress factors in BV-2 cells. Neurobiol Aging 2005; 26: 803–812, [INFOTRIEVE], [CSA], [CROSSREF]
- Anderson R T, et al. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med. 2005; 7: 557–563, [INFOTRIEVE], [CSA]
- Drakesmith H, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005; 106: 1092–1097, [INFOTRIEVE], [CSA], [CROSSREF]
- Zaahl M G, et al. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum Genet. 2004; 115: 409–417, [INFOTRIEVE], [CSA], [CROSSREF]
- Camaschella C, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25: 14–15, [INFOTRIEVE], [CSA], [CROSSREF]
- Camaschella C, et al. A new mutation (G51C) in the iron-responsive element (IRE) of /textscl-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. Br J Haematol. 2000; 108: 480–482, [INFOTRIEVE], [CSA], [CROSSREF]
- Montosi G, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001; 108: 619–623, [INFOTRIEVE], [CSA], [CROSSREF]